Remove participant-info why-participate
article thumbnail

A 360-degree View on Motivators and Deterrents to Clinical Trial Participation

WCG Clinical

Listen and Subscribe: Apple PodCASTs Spotify Google PoDCASTS About this episode: In episode three of WCG Talks Trials , two WCG experts discuss key findings from the 2023 Avoca State of the Industry Report , which provides a 360-degree view on motivators and deterrents to clinical trial participation. Gina DiCindio: Sure.

article thumbnail

The Clinical Study Protocol: The Basics

Cloudbyz

For example, the study might be classified as an Observational, Interventional, or Cross-sectional study, followed by an explanation of why the design is the optimal choice for meeting particular objectives of the study. This section defines the criteria for the eligibility of participating subjects.

article thumbnail

Reinventing Site Feasibility: Breaking Away From a Failed Status Quo

WCG Clinical

And, as we all know, roughly 11% of sites fail to enroll a single participant in a trial. As an industry, we know what needs to be achieved, so why aren’t we doing it? Why do we frequently fail at feasibility? Improved Results: Within 24 hours, 110 high-performing investigators expressed interest in participating.